blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3609491

EP3609491 - OMEGA-3 FATTY ACID, HOMOCYSTEIN AND VITAMIN D LEVELS TO IDENTIFY AND ATTENUATE COGNITIVE AGING IN INDIVIDUALS [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  11.12.2020
Database last updated on 14.06.2024
FormerRequest for examination was made
Status updated on  17.01.2020
FormerThe international publication has been made
Status updated on  20.10.2018
Formerunknown
Status updated on  11.04.2018
Most recent event   Tooltip28.05.2024Change - representative 
Applicant(s)For all designated states
Société des Produits Nestlé S.A.
Entre-deux-Villes
1800 Vevey / CH
[2020/08]
Inventor(s)01 / BOWMAN, Gene
Chemin du Boschet 8B
1025 St-Sulpice / CH
02 / HUDRY-LABBE, Julie
Chemin de la Caboletàz 11
1066 Epalinges / CH
03 / SCHMITT, Jeroen Antonius Johannes
Chemin du Général Voruz 13
1510 Moudon / CH
04 / BOSCHAT, Corina
Route du Jorat 112
1000 Lausanne / CH
05 / RIEKER, Claus
Rue du Centre 158
1025 St-Sulpice / CH
 [2020/08]
Representative(s)Gordon, Kirsteen Helen
Marks & Clerk LLP
62-68 Hills Road
Cambridge CB2 1LA / GB
[N/P]
Former [2020/08]Chautard, Cécile
Société des Produits Nestlé S.A.
Avenue Nestlé 55
1800 Vevey / CH
Application number, filing date18714287.205.04.2018
[2020/08]
WO2018EP58701
Priority number, dateUS201762484119P11.04.2017         Original published format: US 201762484119 P
US201762484156P11.04.2017         Original published format: US 201762484156 P
EP2017019391629.09.2017         Original published format: EP 17193916
WO2017EP7473129.09.2017         Original published format: PCT/EP2017/074731
US201762580574P02.11.2017         Original published format: US 201762580574 P
WO2017EP8214811.12.2017         Original published format: PCT/EP2017/082148
[2020/08]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2018189020
Date:18.10.2018
Language:EN
[2018/42]
Type: A2 Application without search report 
No.:EP3609491
Date:19.02.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 18.10.2018 takes the place of the publication of the European patent application.
[2020/08]
Search report(s)International search report - published on:EP18.04.2019
ClassificationIPC:A61K31/202, A61P25/28, A61K31/14, A61K31/4415, A61K31/51, A61K31/592, A61K31/593
[2020/08]
CPC:
A61K31/202 (EP,US); A61K31/714 (EP,US); A61K31/14 (EP,US);
A61K31/198 (EP,US); A61K31/4415 (EP); A61K31/51 (EP);
A61K31/592 (EP,US); A61K31/593 (EP,US); A61P25/28 (EP,US);
G01N33/6896 (US); G01N33/82 (US); G01N2800/2821 (US) (-)
C-Set:
A61K31/14, A61K2300/00 (EP);
A61K31/198, A61K2300/00 (EP);
A61K31/202, A61K2300/00 (EP);
A61K31/4415, A61K2300/00 (EP);
A61K31/51, A61K2300/00 (EP);
A61K31/592, A61K2300/00 (EP);
A61K31/593, A61K2300/00 (EP);
A61K31/714, A61K2300/00 (EP)
(-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/08]
TitleGerman:OMEGA-3-FETTSÄURE-, HOMOCYSTEIN- UND VITAMIN-D-SPIEGEL ZUR IDENTIFIZIERUNG UND ABSCHWÄCHUNG KOGNITIVER ALTERUNG BEI PERSONEN[2020/08]
English:OMEGA-3 FATTY ACID, HOMOCYSTEIN AND VITAMIN D LEVELS TO IDENTIFY AND ATTENUATE COGNITIVE AGING IN INDIVIDUALS[2020/08]
French:ACIDES GRAS OMEGA-3, HOMOCYSTEINE ET VITAMINE D POUR L'IDENTIFICATION D'UNE PRÉDISPOSITION À UN DÉCLIN COGNITIF ET LA RÉDUCTION DU DÉCLIN COGNITIF[2020/08]
Entry into regional phase11.11.2019National basic fee paid 
11.11.2019Designation fee(s) paid 
11.11.2019Examination fee paid 
Examination procedure11.11.2019Examination requested  [2020/08]
11.11.2019Date on which the examining division has become responsible
29.05.2020Amendment by applicant (claims and/or description)
10.12.2020Despatch of a communication from the examining division (Time limit: M04)
31.03.2021Reply to a communication from the examining division
26.07.2022Despatch of a communication from the examining division (Time limit: M04)
28.11.2022Reply to a communication from the examining division
20.03.2024Despatch of a communication from the examining division (Time limit: M02)
15.05.2024Reply to a communication from the examining division
Fees paidRenewal fee
31.03.2020Renewal fee patent year 03
15.04.2021Renewal fee patent year 04
14.03.2022Renewal fee patent year 05
14.03.2023Renewal fee patent year 06
13.03.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO0203074  (AXIS SHIELD ASA [NO], et al) [Y] 12 * page 4, paragraph 2 * * page 8; example 1 *;
 [X]US2002182196  (MCCLEARY EDWARD LARRY [US]) [X] 9,11,13-21 * paragraph [0177] * * paragraph [0001] - paragraph [0003] *;
 [X]WO2010143053  (ENERGY4LIFE AG [CH], et al) [X] 9,11,13-21 * examples 7,8 *;
 [X]WO2011143587  (NITROMEGA CORP [US], et al) [X] 9-11,13-21 * claims 1,6 * * example 24 * * paragraph [0159] *;
 [Y]WO2014122290  (CENTRE NAT RECH SCIENT [FR], et al) [Y] 12 * page 16, paragraph 4 - page 17, paragraph 1 *;
 [X]US2014271844  (MILLER RAYMOND A [US]) [X] 9-11,13-21 * paragraphs [0071] , [0101] * * examples 10-20,6,65,70-75 *;
 [X]US2015086625  (MILLER RAYMOND A [US]) [X] 9-11,13-21 * claims 1,15,19 *;
 [X]WO2015140545  (ISIS INNOVATION [GB]) [X] 9,11,13-21 * claims 1,22,23,28 * * page 24, line 20 - line 35 * * page 32, paragraph 1 *;
 [X]WO2016207794  (NESTEC SA [CH]) [X] 9,11,13-21 * claims 1,4,5 * * paragraph [0034] * * paragraph [0086] - paragraph [0087] *;
 [X]WO2017004436  (UNIV CALIFORNIA [US]) [X] 9-21 * paragraph [0324]; example 2 * * paragraph [0328]; table 6 * * claims 1,59-66 * * paragraph [0234] *;
 [IY]  - BARBERGER-GATEAU P, "Nutrition and brain aging: How can we move ahead?", EUROPEAN JOURNAL OF CLINICAL NUTRITION, NATURE PUBLISHING GROUP, GB, (20141113), vol. 68, no. 11, doi:10.1038/EJCN.2014.177, ISSN 0954-3007, pages 1245 - 1249, XP009503472 [I] 1-11,13-21 * abstract * * page 1246, paragraph 1 * [Y] 12

DOI:   http://dx.doi.org/10.1038/ejcn.2014.177
 [X]  - BOWMAN GENE ET AL, "Nutrient biomarker patterns and cognitive decline in older adults", THE FASEB JOURNAL, FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY, US, (20140331), vol. 28, no. 1, Suppl. S, ISSN 0892-6638, page 124.6, XP009503473 [X] 1-8 * the whole document *
by applicant   - SCHMITT et al., Nutrition Reviews, (20100000), vol. 68, pages S2 - S5
    - MCMAHON et al., N Engl J Med, (20060000), vol. 354, no. 26, pages 2764 - 2772
    - HANKEY et al., Stroke, (20130000), vol. 44, no. 8, pages 2232 - 2239
    - LEWERIN et al., Am J Clin Nutr, (20050000), vol. 81, no. 5, pages 1155 - 1162
    - HUGHES et al., Br. J. Psychiatry, (19820000), vol. 140, pages 566 - 72
    - FOLSTEIN et al., J. Psychiat. Res., (19750000), vol. 12, pages 189 - 198
    - GALASKO et al., Alzheimer Dis. Assoc. Disord., (19970000), vol. 11, no. 2, pages 33 - 9
    - GANGULY P et al., Nutr J, (20150000), vol. 14, page 6
    - FEART C et al., Alzheimers Dement, (20170000), vol. 13, pages 1207 - 1216
    - GOODWILL AM et al., J Am Geriatr Soc, (20170000), vol. 65, pages 2161 - 2168
    - STARK KD et al., Prog Lipid Res, (20160000), vol. 63, pages 132 - 152
    - HEUDE B et al., Am J Clin Nutr, (20030000), vol. 77, pages 803 - 808
    - ANDRIEU S et al., Lancet Neurol, (20170000), vol. 16, pages 377 - 389
    - VELLAS B et al., J Prev Alzheimers Dis, (20140000), vol. 1, pages 13 - 22
    - GROBER E et al., Neurology, (19880000), vol. 38, pages 900 - 903
    - CARDEBAT D et al., Acta Neurol Belg, (19900000), vol. 90, pages 207 - 217
    - LEGRAND P et al., Lipids, (20100000), vol. 45, pages 11 - 19
    - HOLICK MF et al., Ann Epidemiol, (20090000), vol. 19, pages 73 - 78
    - DOU C et al., Clin Chem, (20050000), vol. 51, pages 1987 - 1989
    - BOWMAN GL et al., Front Aging Neurosci, (20130000), vol. 5, page 92
    - MILLER JW et al., JAMA Neurol, (20150000), vol. 72, pages 1295 - 1303
    - DAYON L et al., Alzheimers Res Ther, (20170000), vol. 9, page 43
    - TAN ZS et al., Neurology, (20120000), vol. 78, pages 658 - 664
    - HOOPER C et al., J Nutr Health Aging, (20170000), vol. 21, pages 988 - 993
    - ROSS AC et al., J Clin Endocrinol Metab, (20110000), vol. 96, pages 53 - 58
    - SESHADRI S et al., N Engl J Med, (20020000), vol. 346, pages 476 - 483
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.